Gut bacteria may contribute to blood pressure drug resistance
By studying the gut microbes of rats, researchers discovered that a bacteria known as Coprococcus comes contributes to resistance to high blood pressure drugs.
List view / Grid view
By studying the gut microbes of rats, researchers discovered that a bacteria known as Coprococcus comes contributes to resistance to high blood pressure drugs.
New research could point towards a way to restore immune function in patients with immune disorders involving B cell signalling deficiencies.
Researchers at the Weizmann Institute of Science have shown that fibroblasts may be a factor in the origin of scleroderma.
Researchers have found that the Lamin B1 mutation causes odd-shaped nuclei in blood cancer cells, which may lead to improved care for leukaemia patients.
Researchers have discovered how immune system dendritic cells are key to maintaining and regulating response to immunotherapy.
Scientists at Northwestern Medicine have developed new techniques in human blood to pave potential paths towards a HIV cure.
Researchers at Hubrecht Institute, Netherlands have developed a technique to measure both gene expression and DNA packaging at the same time.
A new study has found that mycobacteria are associated with red blood cells at lung infection sites, an interaction that has escaped scientists for 140 years.
After two decades, researchers have generated the first complete, gapless sequence of a human genome
Scientists have opened a path towards triple-negative breast cancer treatment, by creating organoids from tumour samples.
A new study in zebrafish has shown the Hand2 protein may play a role in the origin of mesothelioma, presenting a target.
Pre-clinical research in newborn rats found that a nanotherapy could prevent chronic lung disease in premature babies.
New research has found that immune cells produce a chemical messenger that prevents heart disease–related inflammation
Scientists have developed a genetic screening platform to identify genes that can enhance immune cells to make them more persistent and increase their ability to eradicate tumour cells.
Researchers have developed a pH-sensitive drug delivery system in T cells using C-terminal dendrimers with Phenylalanine.